• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Fate of new three anti-influenza drugs and one prodrug in the water environment

tetano

Editor, Senior Moderator
Chemosphere. 2016 Nov 26;169:550-557. doi: 10.1016/j.chemosphere.2016.11.102. [Epub ahead of print]
[h=1]Fate of new three anti-influenza drugs and one prodrug in the water environment.[/h] Azuma T[SUP]1[/SUP], Ishida M[SUP]2[/SUP], Hisamatsu K[SUP]2[/SUP], Yunoki A[SUP]2[/SUP], Otomo K[SUP]2[/SUP], Kunitou M[SUP]2[/SUP], Shimizu M[SUP]2[/SUP], Hosomaru K[SUP]2[/SUP], Mikata S[SUP]2[/SUP], Mino Y[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We evaluated the environmental fate of new three anti-influenza drugs, favipiravir (FAV), peramivir (PER), and laninamivir (LAN), and an active prodrug of LAN, laninamivir octanoate (LANO), in comparison with four conventional drugs, oseltamivir (OS), oseltamivir carboxylate (OC), amantadine (AMN), and zanamivir (ZAN) by photodegradation, biodegradation, and sorption to river sediments. In addition, we conducted 9-month survey of urban rivers in the Yodo River basin from 2015 to 2016 (including the influenza season) to investigate the current status of occurrence of these drugs in the river environment. The results clearly showed that FAV and LAN rapidly disappeared through photodegradation (half-lives 1 and 8 h, respectively), followed by LANO which gradually disappeared through biodegradation (half-life, 2 days). The remained PER and conventional drugs were, however, persistent and transported from upstream to downstream sites. Rates of their sorption to river sediments were negligibly small. Detected levels remained were in the range from N.D. to 89 ng/L for the river waters and from N.D. to 906 ng/L in sewage effluent. However, all of the remained drugs were effectively removed by ozonation after chlorination at a sewage treatment plant. These findings suggest the importance of introducing ozonation for reduction of pollution loads in rivers, helping to keep river environments safe. To the best of our knowledge, this is the first evaluation of the removal effects of natural sunlight, biodegradation, and sorption to river sediments on FAV, PER, LAN, LANO, and a conventional drug, AMN.
Copyright © 2016 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Avigan; Biodegradation; Inavir; Photolysis; Rapiacta; Sorption

PMID: 27898328 DOI: 10.1016/j.chemosphere.2016.11.102
[PubMed - as supplied by publisher]
 
Back
Top Bottom